Post menopausal bleeding Post menopausal bleeding Endometrial sampling Lidocaine jelly Pain score
Conditions
Interventions
2% lidocaine jelly and sterile gel 3 ml,sterile gel 3 ml
Experimental Drug,Placebo Comparator Drug
Lidocaine jelly,Placebo
Sponsors
None listed
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: women who were diagnosed with post menopausal bleeding and were literate, mature, and stable enough to do the visual analog score (VAS).
Exclusion criteria
Exclusion criteria: 1.allergy to lidocaine jelly 2.unstable vital signs for example systolic blood pressure (SBP) lower than 90 mmHg., diastolic blood pressure (SBP) lower than 60 mmHg., pulse rate more than 120 bpm., 3.patient unconsciousness or unable to answer the question and pain score.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the pain score when finishing endometrial sampling finishing endometrial sampling VAS,the pain score when finishing the procedure for 10 min when finishing the procedure for 10 min VAS,the pain score when start endometrial sampling when start endometrial sampling VAS | — |
Secondary
| Measure | Time frame |
|---|---|
| satisfied finishing the procedure for 10 min score (1-10) | — |
Countries
Thailand
Contacts
Public ContactNathnicha Kanchana
Maharat Nakhon Ratchasima Hospital
Outcome results
None listed